Ranitidine Lawsuit Update 2025. Zantac lawsuits arose from its active ingredient, ranitidine, which degrades into a carcinogenic substance. By christian moess laursen and dominic chopping.

Zantac lawsuits arose from its active ingredient, ranitidine, which degrades into a carcinogenic substance. In line with its attending safety concerns, the fda urged ranitidine manufacturers to withdraw their products from the market.